Literature DB >> 9799704

Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength.

R Gruetter1, S A Weisdorf, V Rajanayagan, M Terpstra, H Merkle, C L Truwit, M Garwood, S L Nyberg, K Uğurbil.   

Abstract

The measurement of cerebral metabolites using highly homologous localization techniques and similar shimming methods was performed in the human brain at 1.5 and 4 T as well as in the dog and rat brain at 9.4 T. In rat brain, improved resolution was achieved by shimming all first- and second-order shim coils using a fully adiabatic FASTMAP sequence. The spectra showed a clear improvement in spectral resolution for all metabolite resonances with increased field strength. Changes in cerebral glutamine content were clearly observed at 4 T compared to 1.5 T in patients with hepatic encephalopathy. At 9.4 T, glutamine H4 at 2.46 ppm was fully resolved from glutamate H4 at 2.37 ppm, as was the potential resonance from gamma-amino-butyric acid at 2.30 ppm and N-acetyl-aspartyl-glutamate at 2.05 ppm. Singlet linewidths were found to be as low as 6 Hz (0.015 ppm) at 9.4 T, indicating a substantial decrease in ppm linewidth with field strength. Furthermore, the methylene peak of creatine was partially resolved from phosphocreatine, indicating a close to 1:1 relationship in gray matter. We conclude that increasing the magnetic field strength increases spectral resolution also for 1H NMR, which can lead to more than linear sensitivity gains. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799704     DOI: 10.1006/jmre.1998.1542

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  39 in total

1.  Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison.

Authors:  O Gonen; S Gruber; B S Li; V Mlynárik; E Moser
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

Review 2.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 3.  [(1)H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla].

Authors:  F Fischbach; M Thormann; J Ricke
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

4.  Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.

Authors:  X Yao; M Zeng; H Wang; S Fei; S Rao; Y Ji
Journal:  Radiol Med       Date:  2011-11-17       Impact factor: 3.469

5.  Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia.

Authors:  Melissa Terpstra; T J Vaughan; Kamil Ugurbil; Kelvin O Lim; S Charles Schulz; Rolf Gruetter
Journal:  MAGMA       Date:  2005-11-18       Impact factor: 2.310

6.  MR Spectroscopy in the diagnosis and treatment of breast cancer.

Authors:  Michael T Nelson; Lenore I Everson; Michael Garwood; Tim Emory; Patrick J Bolan
Journal:  Semin Breast Dis       Date:  2008-06-01

Review 7.  Metabolite quantification and high-field MRS in breast cancer.

Authors:  Ihab S Haddadin; Adeka McIntosh; Sina Meisamy; Curt Corum; Angela L Styczynski Snyder; Nathaniel J Powell; Michael T Nelson; Douglas Yee; Michael Garwood; Patrick J Bolan
Journal:  NMR Biomed       Date:  2009-01       Impact factor: 4.044

8.  Improved localization, spectral quality, and repeatability with advanced MRS methodology in the clinical setting.

Authors:  Dinesh K Deelchand; Kejal Kantarci; Gülin Öz
Journal:  Magn Reson Med       Date:  2017-06-15       Impact factor: 4.668

9.  In vivo 7.0-tesla magnetic resonance imaging of the wrist and hand: technical aspects and applications.

Authors:  Klaus M Friedrich; Gregory Chang; Renata L R Vieira; Ligong Wang; Graham C Wiggins; Mark E Schweitzer; Ravinder R Regatte
Journal:  Semin Musculoskelet Radiol       Date:  2009-02-23       Impact factor: 1.777

10.  In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease.

Authors:  A Orlacchio; F Bolacchi; M Angelico; A Mancini; V Cozzolino; M Cadioli; G Simonetti
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.